Phoxillum Injection
Product Images NDC 24571-116

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Phoxillum (NDC 24571-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vantive Us Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

An illustrated diagram of an intravenous injection bag labeled PRISMASOL BGK2/3.5 showing its components: a small compartment A with a peel seal, a large compartment B, an injection connector (spike connector), and a Luer connector at the bottom.*

FDA Label Image

Figure 2 (Image 02)

A black and white instructional diagram showing two hands holding the top of an intravenous bag with an arrow pointing downward along the bag, suggesting a step in the preparation or activation process before use.*

FDA Label Image

Figure 3 (Image 03)

Illustration showing two hands squeezing a flexible medical bag from the sides. The arrows indicate pressing inward toward the center of the bag, which appears to be filled with fluid. The bag has several ports at the top and bottom for intravenous use.*

FDA Label Image

Figure 4 (Image 04)

Illustration showing a Luer connector on a fluid bag with a close-up of connecting a tube. The steps show pushing and twisting the connector to attach the tubing securely. This diagram instructs on proper connection technique for intravenous administration equipment.*

FDA Label Image

Image 05

This image shows mixing instructions and detailed drug facts for PrismaSol BGK0/2.5 intravenous injection for continuous renal replacement therapy. It includes a barcode with NDC 24571-108-06, concentrations of potassium (0 mEq/L) and calcium (2.5 mEq/L), ingredient amounts before reconstitution, solution pH and osmolality, storage instructions, and manufacturer information (Baxter Healthcare Corporation). The total volume is 5000 mL.*

FDA Label Image

Figure 7 (Image 06)

This panel contains mixing instructions and detailed composition information for PrismaSol BGK4/2.5 intravenous injection solution. It lists the quantities of calcium chloride, magnesium chloride, dextrose anhydrous, sodium chloride, potassium chloride, lactic acid, and sodium bicarbonate before and after reconstitution. The label includes instructions for use, storage, and manufacturer contact information, noting a 5000 mL package size by Gambro.*

FDA Label Image

Figure 7 (Image 07)

Mixing instruction and formulation label panel for PRISMASOL BGK2/3.5, an intravenous injection solution for continuous renal replacement therapy. The label details solution composition per 1000 mL, including calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium bicarbonate, potassium chloride and related concentrations, volumes of compartments A and B, theoretical osmolarity, pH, and storage instructions. The NDC number and manufacturer (GAMBRO, Baxter Healthcare) are also shown.*

FDA Label Image

Figure 8 (Image 08)

Label for PrismaSol BGK2/0 replacement solution for continuous renal replacement therapy by Vantive US Healthcare LLC. The label shows mixing instructions and detailed ingredient concentrations per 1000 mL after reconstitution, including magnesium chloride 2.03 g, dextrose 20 g, sodium chloride 6.46 g, potassium chloride 0.157 g, lactic acid 5.4 g, and sodium bicarbonate 3.09 g. The total volume is 5000 mL. The label includes electrolyte concentrations in mEq/L and essential product handling information.*

FDA Label Image

Image 09

Drug label text panel for PrismaSol B22GK4/0, a solution for continuous renal replacement therapy. It provides mixing instructions, a barcode with NDC 24571-111-06, and displays major electrolyte concentrations including potassium (4K+ mEq/L), bicarbonate (22), and calcium (0Ca2+ mEq/L). The label lists ingredient concentrations before and after reconstitution in compartments A and B, and includes storage and handling instructions. The labeler is Baxter Healthcare Corporation, manufactured in Italy, with a 5000 mL container size.*

FDA Label Image

Prismasol Representative Container Label Bgk0/2.5 1 Of 2 (Image 10)

The image shows reconstitution and preparation instructions for PrismaSol BGK solution for renal replacement therapy. It details mixing steps, a table of ingredient amounts per 1000 mL before and after reconstitution, including magnesium chloride, sodium chloride, lactic acid, sodium bicarbonate, and water for injections. Important handling and storage precautions are provided. The label includes volume information for compartments A (250 mL) and B (4750 mL), theoretical osmolarity, pH range, and manufacturer details (Baxter Healthcare Corporation).*

FDA Label Image

Prismasol Representative Container Label Bgk0/2.5 2 Of 2 (Image 11)

Label of PRISMASOL BGK4/0/1.2H repletion solution for continuous renal replacement therapy, 5000 mL intravenous injection. Shows drug components and concentrations before and after reconstitution, including magnesium chloride, dextrose anhydrous, sodium chloride, potassium chloride, lactic acid, sodium bicarbonate. Labeler is Vantive US Healthcare LLC. Includes directions to squeeze top and bag sides to open, barcode, and advisory about mixing compartments.*

FDA Label Image

Prismasol Representative Carton Label Bgk0/2.5 (Image 12)

Drug Facts panel for Phoxillum BK4/2.5, a replacement solution for Continuous Renal Replacement Therapy. The panel includes mixing instructions for compartments labeled A and B, a barcode with NDC number, active ingredient concentrations before and after reconstitution, and detailed preparation instructions. The volume is 5000 mL, manufactured by Baxter Healthcare Corporation and distributed by Gambro.*

FDA Label Image

Prismasol Representative Container Label Bgk4/2.5 1 Of 2 (Image 13)

Label for PRISMASOL BGK2/3.5 Phoxillum B22K4/0, an injection replacement solution for continuous renal replacement therapy. It provides electrolyte concentrations including 4 mEq/L potassium, 0 mEq/L calcium, 22 mEq/L bicarbonate, and 1 mmol/L phosphate. The label includes mixing instructions, a barcode with NDC# 24571-117-06, a table of contents before and after reconstitution, and states a total volume of 5000 mL. Manufacturer is Baxter Healthcare Corporation, made in Italy.*

FDA Label Image

Prismasol Representative Container Label Bgk4/2.5 2 Of 2 (Image 14)

Label for PRISMASOL BGK4/3.5, a 5000 mL intravenous replacement solution for continuous renal replacement therapy. The label shows detailed composition per 1000 mL before reconstitution, including calcium chloride, magnesium chloride, dextrose anhydrous, sodium chloride, potassium chloride, lactic acid, and sodium bicarbonate. It indicates two compartments: A (250 mL) and B (4750 mL) to be mixed by breaking the red pin. Manufactured by Gambro Renal Products, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.